Top

Osteoporosis International

Published in:

01-01-2011 | Letter

Denosumab-related osteonecrosis of the jaws

Authors: A. Kyrgidis, K. A. Toulis

Published in: Osteoporosis International | Issue 1/2011

Excerpt

Dear Editors, …

Anastasilakis AD, Toulis KA, Polyzos SA, Terpos E (2009) RANKL inhibition for the management of patients with benign metabolic bone disorders. Expert Opin Investig Drugs 18:1085–1102CrossRefPubMed

Kyrgidis A, Triaridis S, Vahtsevanos K, Antoniades K (2009) Osteonecrosis of the jaw and bisphosphonate use in breast cancer patients. Expert Rev Anticancer Ther 9:1125–1134CrossRefPubMed

Anastasilakis AD, Toulis KA, Goulis DG, Polyzos SA, Delaroudis S, Giomisi A, Terpos E (2009) Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis. Horm Metab Res 41:721–729CrossRefPubMed

Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL (2008) Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol 9:1166–1172CrossRefPubMed

Coleman RE (2008) Risks and benefits of bisphosphonates. Br J Cancer 98:1736–1740CrossRefPubMed

Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg Oct 15. doi:10.1016/j.bjoms.2009.08.030

Henry D, von Moos R, Vadhan-Raj S, Hungria V, Spencer A, Hirsh V, Wang J, Jun S, Yeh H, Dansey R (2009) A double-blind, randomized study of denosumab versus zoledronic acid for the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. European Journal of Cancer Supplements, Vol 7, Issue 3, Joint ECCO 15—34th ESMO Multidisciplinary Congress—Proffered Paper sessions 7(3):12

Stopeck A, Body JJ, Fujiwara Y, Lipton A, Steger GG, Viniegra M, Fan M, Braun A, Dansey R, Jun S (2009) Denosumab versus zoledronic acid for the treatment of breast cancer patients with bone metastases: results of a randomized phase 3 study. European Journal of Cancer Supplements, Vol 7, Issue 3, Joint ECCO 15—34th ESMO Multidisciplinary Congress—Presidential session II 7(3):2–3

Vahtsevanos K, Kyrgidis A, Verrou E, Katodritou E, Triaridis S, Andreadis C, Boukovinas I, Koloutsos G, Teleioudis Z, Kitikidou K, Paraskevopoulos P, Zervas K, Antoniades K (2009) Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol 27:5356–5362CrossRefPubMed

10.

Hess LM, Jeter JM, Benham-Hutchins M, Alberts DS (2008) Factors associated with osteonecrosis of the jaw among bisphosphonate users. Am J Med 121(475–483):e473

11.

Kyrgidis A, Vahtsevanos K (2009) Osteonecrosis of the jaw in patients receiving oral bisphosphonates. Osteoporos Int. doi:10.1007/s00198-009-01089-5 PubMed

12.

Kyrgidis A, Vahtsevanos K (2009) "Fatigue" having a role in the pathogenesis of osteonecrosis of the jaws. Clin Oral Investig 13:479–480CrossRefPubMed

Title: Denosumab-related osteonecrosis of the jaws
Authors: A. Kyrgidis
K. A. Toulis
Publication date: 01-01-2011
Publisher: Springer-Verlag
Published in: Osteoporosis International / Issue 1/2011
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-010-1177-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Denosumab-related osteonecrosis of the jaws

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2011

Dose–response effect of 40 weeks of resistance training on bone mineral density in older adults

Precompetitive and recreational gymnasts have greater bone density, mass, and estimated strength at the distal radius in young childhood

Comparing methods to identify hip fracture in a nursing home population using Medicare claims

Vitamin D sufficiency is associated with low incidence of limb and vertebral fractures in community-dwelling elderly Japanese women: the Muramatsu Study

Bone mineral densities in patients with developmental dysplasia of the hip

Early treatment with zoledronic acid prevents bone loss at the hip following acute spinal cord injury